ID   KPCA_HUMAN              Reviewed;         672 AA.
AC   P17252; Q15137; Q32M72; Q96RE4;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   05-OCT-2010, entry version 131.
DE   RecName: Full=Protein kinase C alpha type;
DE            Short=PKC-A;
DE            Short=PKC-alpha;
DE            EC=2.7.11.13;
GN   Name=PRKCA; Synonyms=PKCA, PRKACA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Blood;
RX   MEDLINE=90245676; PubMed=2336401; DOI=10.1093/nar/18.8.2183;
RA   Finkenzeller G., Marme D., Hug H.;
RT   "Sequence of human protein kinase C alpha.";
RL   Nucleic Acids Res. 18:2183-2183(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT VAL-568.
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R.,
RA   Gnerre S., Goldstein S., Grafham D.V., Grocock R., Hafez N.,
RA   Hagopian D.S., Hart E., Norman C.H., Humphray S., Jaffe D.B.,
RA   Jones M., Kamal M., Khodiyar V.K., LaButti K., Laird G., Lehoczky J.,
RA   Liu X., Lokyitsang T., Loveland J., Lui A., Macdonald P., Major J.E.,
RA   Matthews L., Mauceli E., McCarroll S.A., Mihalev A.H., Mudge J.,
RA   Nguyen C., Nicol R., O'Leary S.B., Osoegawa K., Schwartz D.C.,
RA   Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in
RT   the human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 15-445.
RX   MEDLINE=91332033; PubMed=1714454;
RA   McSwine-Kennick R.L., McKeegan E.M., Johnson M.D., Morin M.J.;
RT   "Phorbol diester-induced alterations in the expression of protein
RT   kinase C isozymes and their mRNAs. Analysis in wild-type and phorbol
RT   diester-resistant HL-60 cell clones.";
RL   J. Biol. Chem. 266:15135-15143(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-57.
RA   Haridasse V., Hackenbruck J., Glazer R.I.;
RT   "Homo sapiens protein kinase C alpha 5-flanking sequence.";
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   PROTEIN SEQUENCE OF 2-19.
RC   TISSUE=Platelet;
RX   MEDLINE=22608298; PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   INTERACTION WITH ADAP1.
RX   MEDLINE=22774667; PubMed=12893243; DOI=10.1016/S0006-291X(03)01187-2;
RA   Zemlickova E., Dubois T., Kerai P., Clokie S., Cronshaw A.D.,
RA   Wakefield R.I.D., Johannes F.-J., Aitken A.;
RT   "Centaurin-alpha(1) associates with and is phosphorylated by isoforms
RT   of protein kinase C.";
RL   Biochem. Biophys. Res. Commun. 307:459-465(2003).
RN   [8]
RP   INTERACTION WITH PICK1.
RX   PubMed=15247289; DOI=10.1074/jbc.M404499200;
RA   Dev K.K., Nakanishi S., Henley J.M.;
RT   "The PDZ domain of PICK1 differentially accepts protein kinase C-alpha
RT   and GluR2 as interacting ligands.";
RL   J. Biol. Chem. 279:41393-41397(2004).
RN   [9]
RP   FUNCTION IN PHOSPHORYLATION OF CSPG4, AND INTERACTION WITH CSPG4.
RX   PubMed=15504744; DOI=10.1074/jbc.M411045200;
RA   Makagiansar I.T., Williams S., Dahlin-Huppe K., Fukushi J.,
RA   Mustelin T., Stallcup W.B.;
RT   "Phosphorylation of NG2 proteoglycan by protein kinase C-alpha
RT   regulates polarized membrane distribution and cell motility.";
RL   J. Biol. Chem. 279:55262-55270(2004).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226 AND SER-319, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-319, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein
RT   phosphorylation analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-195, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [13]
RP   INTERACTION WITH TRIM41.
RX   PubMed=17893151; DOI=10.1074/jbc.M703320200;
RA   Chen D., Gould C., Garza R., Gao T., Hampton R.Y., Newton A.C.;
RT   "Amplitude control of protein kinase C by RINCK, a novel E3 ubiquitin
RT   ligase.";
RL   J. Biol. Chem. 282:33776-33787(2007).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226; THR-497; THR-501;
RP   THR-638 AND TYR-658, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-319, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-208; SER-226; SER-319
RP   AND THR-497, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-604 AND LYS-628, AND MASS
RP   SPECTROMETRY.
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [22]
RP   STRUCTURE BY NMR OF 88-169.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the second phorbol esters/diacylglycerol
RT   binding domain of human protein kinase C alpha type.";
RL   Submitted (APR-2008) to the PDB data bank.
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] SER-98; ASN-467 AND VAL-489.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: This is a calcium-activated, phospholipid-dependent,
CC       serine- and threonine-specific enzyme. May play a role in cell
CC       motility by phosphorylating CSPG4.
CC   -!- FUNCTION: PKC is activated by diacylglycerol which in turn
CC       phosphorylates a range of cellular proteins. PKC also serves as
CC       the receptor for phorbol esters, a class of tumor promoters.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- COFACTOR: Binds 3 calcium ions per subunit. The ions are bound to
CC       the C2 domain (By similarity).
CC   -!- SUBUNIT: Interacts with ADAP1/CENTA1, CSPG4 and PRKCABP. Binds to
CC       SDPR in the presence of phosphatidylserine. Interacts with PICK1
CC       (via PDZ domain). Interacts with TRIM41.
CC   -!- INTERACTION:
CC       Q8WV44:TRIM41; NbExp=1; IntAct=EBI-1383528, EBI-725997;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm (By similarity). Cell membrane;
CC       Peripheral membrane protein (By similarity).
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. AGC Ser/Thr
CC       protein kinase family. PKC subfamily.
CC   -!- SIMILARITY: Contains 1 AGC-kinase C-terminal domain.
CC   -!- SIMILARITY: Contains 1 C2 domain.
CC   -!- SIMILARITY: Contains 2 phorbol-ester/DAG-type zinc fingers.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X52479; CAA36718.1; -; mRNA.
DR   EMBL; AC005918; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC005988; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006263; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC006947; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC009452; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC060796; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC109273; AAI09274.1; -; mRNA.
DR   EMBL; BC109274; AAI09275.1; -; mRNA.
DR   EMBL; M22199; AAA60098.1; -; mRNA.
DR   EMBL; AF395829; AAK84184.1; -; Genomic_DNA.
DR   IPI; IPI00385449; -.
DR   PIR; S09496; KIHUCA.
DR   RefSeq; NP_002728.1; -.
DR   UniGene; Hs.531704; -.
DR   UniGene; Hs.708867; -.
DR   PDB; 2ELI; NMR; -; A=92-169.
DR   PDB; 3IW4; X-ray; 2.80 A; A/B/C=320-672.
DR   PDBsum; 2ELI; -.
DR   PDBsum; 3IW4; -.
DR   ProteinModelPortal; P17252; -.
DR   SMR; P17252; 37-106, 156-292.
DR   DIP; DIP-531N; -.
DR   IntAct; P17252; 3.
DR   MINT; MINT-140812; -.
DR   STRING; P17252; -.
DR   PhosphoSite; P17252; -.
DR   PRIDE; P17252; -.
DR   Ensembl; ENST00000284384; ENSP00000284384; ENSG00000154229.
DR   GeneID; 5578; -.
DR   KEGG; hsa:5578; -.
DR   UCSC; uc002jfp.1; human.
DR   CTD; 5578; -.
DR   GeneCards; GC17P064298; -.
DR   H-InvDB; HIX0014097; -.
DR   HGNC; HGNC:9393; PRKCA.
DR   HPA; CAB003844; -.
DR   HPA; CAB016290; -.
DR   HPA; HPA006563; -.
DR   HPA; HPA006564; -.
DR   MIM; 176960; gene.
DR   PharmGKB; PA33759; -.
DR   eggNOG; prNOG05005; -.
DR   HOGENOM; HBG755340; -.
DR   HOVERGEN; HBG108317; -.
DR   InParanoid; P17252; -.
DR   PhylomeDB; P17252; -.
DR   BRENDA; 2.7.11.13; 247.
DR   Pathway_Interaction_DB; a6b1_a6b4_integrin_pathway; a6b1 and a6b4 Integrin signaling.
DR   Pathway_Interaction_DB; nfkappabcanonicalpathway; Canonical NF-kappaB pathway.
DR   Pathway_Interaction_DB; cd8tcrdownstreampathway; Downstream signaling in naive CD8+ T cells.
DR   Pathway_Interaction_DB; endothelinpathway; Endothelins.
DR   Pathway_Interaction_DB; tcrraspathway; Ras signaling in the CD4+ TCR pathway.
DR   Pathway_Interaction_DB; retinoic_acid_pathway; Retinoic acid receptors-mediated signaling.
DR   Pathway_Interaction_DB; nfat_3pathway; Role of Calcineurin-dependent NFAT signaling in lymphocytes.
DR   Pathway_Interaction_DB; vegfr1_2_pathway; Signaling events mediated by VEGFR1 and VEGFR2.
DR   Pathway_Interaction_DB; ret_pathway; Signaling events regulated by Ret tyrosine kinase.
DR   Pathway_Interaction_DB; syndecan_4_pathway; Syndecan-4-mediated signaling events.
DR   Pathway_Interaction_DB; tcrpathway; TCR signaling in naive CD4+ T cells.
DR   Pathway_Interaction_DB; cd8tcrpathway; TCR signaling in naive CD8+ T cells.
DR   Pathway_Interaction_DB; txa2pathway; Thromboxane A2 receptor signaling.
DR   Pathway_Interaction_DB; vegfr1_pathway; VEGFR1 specific signals.
DR   Reactome; REACT_11061; Signalling by NGF.
DR   Reactome; REACT_13685; Synaptic Transmission.
DR   Reactome; REACT_14797; Signaling by GPCR.
DR   Reactome; REACT_1505; Integration of energy metabolism.
DR   Reactome; REACT_15295; Opioid Signalling.
DR   Reactome; REACT_15380; Diabetes pathways.
DR   Reactome; REACT_604; Hemostasis.
DR   BindingDB; P17252; -.
DR   DrugBank; DB00144; Phosphatidylserine.
DR   DrugBank; DB00163; Vitamin E.
DR   NextBio; 21628; -.
DR   PMAP-CutDB; P17252; -.
DR   ArrayExpress; P17252; -.
DR   Bgee; P17252; -.
DR   CleanEx; HS_PRKACA; -.
DR   CleanEx; HS_PRKCA; -.
DR   Genevestigator; P17252; -.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0019899; F:enzyme binding; IPI:BHF-UCL.
DR   GO; GO:0035403; F:histone kinase activity (H3-T6 specific); IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0008624; P:induction of apoptosis by extracellular sig...; TAS:ProtInc.
DR   GO; GO:0070555; P:response to interleukin-1; IMP:BHF-UCL.
DR   InterPro; IPR000961; AGC-kinase_C.
DR   InterPro; IPR000008; C2_Ca-dep.
DR   InterPro; IPR008973; C2_Ca/lipid-bd_dom_CaLB.
DR   InterPro; IPR018029; C2_membr_targeting.
DR   InterPro; IPR020477; C2_region.
DR   InterPro; IPR020454; DAG/PE-bd.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR015745; PKC.
DR   InterPro; IPR017892; Pkinase_C.
DR   InterPro; IPR002219; Prot_Kinase_C-like_PE/DAG-bd.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR014375; Protein_kinase_C_a/b/g.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   PANTHER; PTHR22985:SF86; PKC; 1.
DR   Pfam; PF00130; C1_1; 2.
DR   Pfam; PF00168; C2; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF00433; Pkinase_C; 1.
DR   PIRSF; PIRSF000550; PKC_alpha; 1.
DR   PRINTS; PR00360; C2DOMAIN.
DR   PRINTS; PR00008; DAGPEDOMAIN.
DR   SMART; SM00109; C1; 2.
DR   SMART; SM00239; C2; 1.
DR   SMART; SM00133; S_TK_X; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF49562; C2_CaLB; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51285; AGC_KINASE_CTER; 1.
DR   PROSITE; PS50004; C2; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
DR   PROSITE; PS00479; ZF_DAG_PE_1; 2.
DR   PROSITE; PS50081; ZF_DAG_PE_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Calcium; Cell membrane;
KW   Complete proteome; Cytoplasm; Direct protein sequencing; Kinase;
KW   Membrane; Metal-binding; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Repeat; Serine/threonine-protein kinase; Transferase;
KW   Zinc; Zinc-finger.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2    672       Protein kinase C alpha type.
FT                                /FTId=PRO_0000055679.
FT   DOMAIN      172    260       C2.
FT   DOMAIN      339    597       Protein kinase.
FT   DOMAIN      598    668       AGC-kinase C-terminal.
FT   ZN_FING      36     86       Phorbol-ester/DAG-type 1.
FT   ZN_FING     101    151       Phorbol-ester/DAG-type 2.
FT   NP_BIND     345    353       ATP (By similarity).
FT   ACT_SITE    463    463       Proton acceptor (By similarity).
FT   METAL       186    186       Calcium 1; via carbonyl oxygen (By
FT                                similarity).
FT   METAL       187    187       Calcium 1 (By similarity).
FT   METAL       187    187       Calcium 2 (By similarity).
FT   METAL       193    193       Calcium 2 (By similarity).
FT   METAL       246    246       Calcium 1 (By similarity).
FT   METAL       246    246       Calcium 2 (By similarity).
FT   METAL       247    247       Calcium 2; via carbonyl oxygen (By
FT                                similarity).
FT   METAL       248    248       Calcium 1 (By similarity).
FT   METAL       248    248       Calcium 2 (By similarity).
FT   METAL       248    248       Calcium 3 (By similarity).
FT   METAL       252    252       Calcium 3; via carbonyl oxygen (By
FT                                similarity).
FT   METAL       254    254       Calcium 1 (By similarity).
FT   METAL       254    254       Calcium 3 (By similarity).
FT   BINDING     195    195       Inositol phosphate group (By similarity).
FT   BINDING     245    245       Inositol phosphate group (By similarity).
FT   BINDING     368    368       ATP (By similarity).
FT   MOD_RES       2      2       N-acetylalanine.
FT   MOD_RES     195    195       Phosphotyrosine.
FT   MOD_RES     208    208       Phosphoserine.
FT   MOD_RES     226    226       Phosphoserine.
FT   MOD_RES     319    319       Phosphoserine.
FT   MOD_RES     494    494       Phosphothreonine (By similarity).
FT   MOD_RES     495    495       Phosphothreonine (By similarity).
FT   MOD_RES     497    497       Phosphothreonine.
FT   MOD_RES     501    501       Phosphothreonine.
FT   MOD_RES     604    604       N6-acetyllysine.
FT   MOD_RES     628    628       N6-acetyllysine.
FT   MOD_RES     631    631       Phosphothreonine; by autocatalysis
FT                                (Potential).
FT   MOD_RES     638    638       Phosphothreonine; by autocatalysis.
FT   MOD_RES     657    657       Phosphoserine (By similarity).
FT   MOD_RES     658    658       Phosphotyrosine.
FT   VARIANT      98     98       P -> S (in a colorectal adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042301.
FT   VARIANT     467    467       D -> N (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                /FTId=VAR_042302.
FT   VARIANT     489    489       M -> V (in dbSNP:rs34406842).
FT                                /FTId=VAR_042303.
FT   VARIANT     568    568       I -> V (in dbSNP:rs6504459).
FT                                /FTId=VAR_050558.
FT   CONFLICT     50     50       C -> S (in Ref. 4; AAA60098).
FT   TURN         98    100
FT   STRAND      105    107
FT   STRAND      116    118
FT   STRAND      125    127
FT   STRAND      129    131
FT   STRAND      133    135
FT   STRAND      138    140
FT   TURN        141    146
SQ   SEQUENCE   672 AA;  76764 MW;  8780DD50388C12DA CRC64;
     MADVFPGNDS TASQDVANRF ARKGALRQKN VHEVKDHKFI ARFFKQPTFC SHCTDFIWGF
     GKQGFQCQVC CFVVHKRCHE FVTFSCPGAD KGPDTDDPRS KHKFKIHTYG SPTFCDHCGS
     LLYGLIHQGM KCDTCDMNVH KQCVINVPSL CGMDHTEKRG RIYLKAEVAD EKLHVTVRDA
     KNLIPMDPNG LSDPYVKLKL IPDPKNESKQ KTKTIRSTLN PQWNESFTFK LKPSDKDRRL
     SVEIWDWDRT TRNDFMGSLS FGVSELMKMP ASGWYKLLNQ EEGEYYNVPI PEGDEEGNME
     LRQKFEKAKL GPAGNKVISP SEDRKQPSNN LDRVKLTDFN FLMVLGKGSF GKVMLADRKG
     TEELYAIKIL KKDVVIQDDD VECTMVEKRV LALLDKPPFL TQLHSCFQTV DRLYFVMEYV
     NGGDLMYHIQ QVGKFKEPQA VFYAAEISIG LFFLHKRGII YRDLKLDNVM LDSEGHIKIA
     DFGMCKEHMM DGVTTRTFCG TPDYIAPEII AYQPYGKSVD WWAYGVLLYE MLAGQPPFDG
     EDEDELFQSI MEHNVSYPKS LSKEAVSICK GLMTKHPAKR LGCGPEGERD VREHAFFRRI
     DWEKLENREI QPPFKPKVCG KGAENFDKFF TRGQPVLTPP DQLVIANIDQ SDFEGFSYVN
     PQFVHPILQS AV
//
